Correlation Analysis
Biogen Inc. Common Stock vs JPMorgan Chase & Co.
BIIB vs JPM
-0.708
Strong inverse
When one moves up, the other tends to move down.
Biogen Inc. Common Stock
↗BIIB
Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).
Market cap 25.3B · 7,500 employees
JPMorgan Chase & Co.
↗JPM
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with more than $4.4 trillion in assets. It is organized into four major segments: consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates and is subject to regulation in multiple countries.
Market cap 792.5B
Time Series
Relative Performance
Who Moves First
BIIB leads JPM by 6 days
BIIB tends to move before JPM.
After testing 13 timing shifts, the strongest relationship was -0.710 (they moved in opposite directions).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
-0.138
12 periods · Return correlation when both series rose
Both Falling
-0.011
10 periods · Return correlation when both series fell
Diverging
-0.556
13 periods · Return correlation when series moved apart
R-Squared
50.1%
Share of variance in one series explained by the other.
Trend Agreement
57.5%
How often both series moved in the same direction period-to-period.
Overlap Quality
1,253
Deep shared window — 1,253 usable pairs.
Significance
p < 0.001
95% CI: [-0.734, -0.679]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
1,253 paired data points survived the daily window.
Raw input
1,253
1,254
Normalized
1,253
1,254
Prepared
1,253
1,254
Aligned
1,253
1,253
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
1
A: 0 / B: 1
Series A
Biogen Inc. Common Stock
BIIB
Market cap 25.3B · 7,500 employees
Stock · 1,253 raw → 1,253 prepared
Series B
JPMorgan Chase & Co.
JPM
Market cap 792.5B
Stock · 1,254 raw → 1,254 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
13
Estimated crossover points between normalized spreads.
Slope
-0.7465
Linear regression slope.
Intercept
357.5392
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
Saved 7 hours ago · ID: stock-biib-vs-stock-jpm-daily